In This Section
Judy E. Garber, MD, MPH

Judy E. Garber, MD, MPH

Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts

Class of 2013

An internationally recognized leader in clinical and translational research on breast cancer, Dr. Garber developed one of the first cancer risk and prevention clinics where programs are now being expanded to several types of cancer. She has led studies of epidemiology, cancer surveillance, cancer genetics service delivery, and chemoprevention in hereditary cancers.

Dr. Garber’s recent research has evaluated novel agents targeting DNA repair defects in treatment and prevention of triple-negative or basal-like breast cancer, the most common form of cancer in women with germline BRCA1 mutations. She has also studied pediatric cancers and sarcomas in Li-Fraumeni and hereditary gastrointestinal and stromal tumors.

Career Highlights

2019 ASCO American Cancer Society Award and Lecture
2018 Giants of Cancer Care, OncLive®, Cranbury, New Jersey
2017 AACR-Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research
2012 Elected Member, American Association of Physicians
2011-2012 President, AACR
2011 Professor of Medicine, Harvard Medical School
2010 Director, Center for Cancer Genetics and Prevention, Dana Farber Cancer Institute
2010 Axia Award, Hellenic Women’s Club
2009 Claire W. and Richard P. Morse Research Award, Dana Farber Cancer Institute
2008 Statesman Award, American Society for Clinical Oncology
2007 Tisch Family Outstanding Achievement Award, Dana Farber Cancer Institute
2007-2010 Board of Directors, AACR
2001 Elected to American Society for Clinical Investigation
1997-2000 Scholar in Clinical Research, The Dyson Foundation
1981 MD, MPH, Yale University School of Medicine